Skip to content
value.today
Synthetic Genomics Inc. logo

Synthetic Genomics Inc.

Formerly Synthetic Genomic Solutions, Inc.

Total raised
$45 M
2 rounds on record
Latest round
$10 M
Jan 2013
First round on record
Jun 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Synthetic Genomics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2013$10 MNo. 2$10 to $50 million

Synthetic Genomics Inc.: Raise no. 2, Jan 2013

Investors in this round

1 investor had bought by the notice of Feb 5, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $100 M offered; $90 M still to sell
Smallest investment taken
$11
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hamilton Smith · Executive Officer, Director
  • J. Craig Venter · Executive Officer, Director
  • Jim Flatt · Executive Officer
  • Joseph Mahler · Executive Officer
  • Alfonso Romo · Director
  • Barry Schuler · Director
  • David Kiernan · Director
  • Greg Lucier · Director
  • Juan Enriquez · Director
  • Steve Jurvetson · Director
  • Tan Sri Lim Kok Thay · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Mahler, Cfo. Source: SEC Form D, newest notice filed Feb 5, 2013. Read the notice at the SEC.

equitySEC
Jun 2010$35 MNo. 1$10 to $50 million

Synthetic Genomics Inc.: Raise no. 1, Jun 2010

Investors in this round

6 investors had bought by the notice of Jan 4, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $50 M offered; $15 M still to sell
Smallest investment taken
$2,500,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aristides T. Patrinos · Executive Officer
  • Hamilton O. Smith · Executive Officer, Director
  • J. Craig Venter · Executive Officer, Director
  • Walter J. McBride · Executive Officer
  • Alfonso Romo Garza · Director
  • Barry Romo Schuler · Director
  • David C. Kiernan · Director
  • Gregory T. Lucier · Director
  • Juan C. Enriquez · Director
  • Steve Romo Jurvetson · Director
  • Tan Sri Lim Kok Romo Thay · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Aristides A.N. Patrinos, President. Source: SEC Form D and 1 amendment, newest notice filed Jan 4, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Synthetic Genomics Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2013).

    SEC Form D · Feb 2013

  • The industry group it chose in its notices: Other Energy.

    SEC Form D · Feb 2013

That is all the official record says: Synthetic Genomics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

In its own words

How the company describes itself to search engines on its website, word for word.

“Online casinos that Canadian players can trust for real money play, with top picks for Interac, fast payouts, bonuses, and game variety.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Synthetic Genomics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Synthetic Genomics Inc.
NameRoleNamed in
Hamilton SmithExecutive officerFeb 2013
J. Craig VenterExecutive officerFeb 2013
Jim FlattExecutive officerFeb 2013
Joseph MahlerExecutive officerFeb 2013
Aristides T. PatrinosExecutive officerJan 2011
Hamilton O. SmithExecutive officerJan 2011
Walter J. McBrideExecutive officerJan 2011
Aristides Romo PatrinosExecutive officerJun 2010
Joel Romo McCombExecutive officerJun 2010
Alfonso RomoDirectorFeb 2013
Barry SchulerDirectorFeb 2013
David KiernanDirectorFeb 2013
Greg LucierDirectorFeb 2013
Hamilton SmithDirectorFeb 2013
J. Craig VenterDirectorFeb 2013
Juan EnriquezDirectorFeb 2013
Steve JurvetsonDirectorFeb 2013
Tan Sri Lim Kok ThayDirectorFeb 2013
Alfonso Romo GarzaDirectorJan 2011
Barry Romo SchulerDirectorJan 2011
David C. KiernanDirectorJan 2011
Gregory T. LucierDirectorJan 2011
Hamilton O. SmithDirectorJan 2011
Juan C. EnriquezDirectorJan 2011
Steve Romo JurvetsonDirectorJan 2011
Tan Sri Lim Kok Romo ThayDirectorJan 2011

About

Company in La Jolla, United States.